Skip to main content
. 2024 Sep 25;8(9):e70013. doi: 10.1002/hem3.70013

Table 2.

Common co‐occurrent mutations with NUP98 fusions in AML.

Co‐occurrent mutations Fusion partner References
FLT3‐ITD NSD1, KDM5A, LNP1, HOXC11, HOXA9, HOXA13, HOXD13, NSD3 [14, 18, 116, 117, 118]
WT1 NSD1, KDM5A, TOP1, HOXC11, HOXA9, HOXD11, NSD3, HOXA13, HOXA11 [14, 18, 116, 118]
NRAS NSD1, HOXA9, HOXA11, DDX10 [14, 56, 118]
KRAS HOXA9, HOXD11 [11, 118]
RB1 KDM5A [62, 119]
NOTCH1 RAP1GDS1 [117]
MYC NSD1 [62, 120, 121]
KIT HOXC11, HOXA9, NSD3, NSD1 [118]
RUNX1 NSD1, RARG [122, 123]
ASXL1 NSD1 [124]
MYB RAP1GDS1 [117]